4//SEC Filing
MAGRAB E. BRENDAN 4
Accession 0000899243-17-018593
CIK 0001042418other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 7:41 PM ET
Size
6.0 KB
Accession
0000899243-17-018593
Insider Transaction Report
Form 4
MAGRAB E. BRENDAN
DirectorChairman of the Board
Transactions
- Award
Restricted Stock Units
2017-05-04+65,000→ 65,000 total→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on May 4, 2017, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The RSUs will vest in full on January 1, 2018, provided that if such vesting date is not during an open trading window, then such RSUs will vest on the first day that thereafter that is during an open trading window.
Documents
Issuer
HedgePath Pharmaceuticals, Inc.
CIK 0001042418
Entity typeother
Related Parties
1- filerCIK 0001196062
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 7:41 PM ET
- Size
- 6.0 KB